Eyepoint Pharmaceuticals (EYPT) Stock Chart & Stock Price History $8.42 -0.50 (-5.61%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$8.62 +0.20 (+2.32%) As of 06/20/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eyepoint Pharmaceuticals Stock Price Performance The Eyepoint Pharmaceuticals (EYPT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 0.59%, with a year-to-date return of 13.02%. In the past month, the stock has increased 50.36%, reflecting recent market activity. As of the latest close, Eyepoint Pharmaceuticals traded at $8.42 with a market cap of $579.38 million and volume of 601,634 shares. Five years ago, the stock traded at a split-adjusted price of $88.61, representing a 90.50% decrease over that period. At the time, it had a market cap of $109.75 million and a volume of 11.28 million shares. Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.43%1 Month Performance+50.36%3 Month Performance+34.72%Year-To-Date Performance+13.02%1 Year Performance-0.59%5 Year Performance-90.50% EYPT Stock Chart for Sunday, June, 22, 2025 EYPT Chart by TradingView Eyepoint Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/20/2025$8.92$8.42-5.61%$9.13$8.37601,634 shs$579.38 million06/19/2025$8.92$8.92$9.18$8.60457,955 shs$613.79 million06/18/2025$8.81$8.92+1.25%$9.18$8.60457,955 shs$613.79 million06/17/2025$8.90$8.81-1.01%$9.60$8.78812,342 shs$606.23 million06/16/2025$9.03$8.90-1.44%$9.17$8.71448,176 shs$612.42 million06/13/2025$8.86$9.03+1.92%$9.04$8.50822,461 shs$621.36 million06/12/2025$8.81$8.86+0.57%$9.02$8.60790,408 shs$609.67 million06/11/2025$9.21$8.81-4.34%$9.36$8.72829,333 shs$606.23 million06/10/2025$8.93$9.21+3.14%$9.55$8.91891,944 shs$633.75 million06/09/2025$8.94$8.93-0.11%$9.17$8.75499,647 shs$614.48 million Get the Latest News and Ratings for EYPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/06/2025$8.25$8.94+8.36%$9.09$8.27910,330 shs$615.17 million06/05/2025$8.20$8.25+0.61%$8.31$7.98466,704 shs$567.69 million06/04/2025$8.12$8.20+0.99%$8.36$8.01635,138 shs$564.25 million06/03/2025$7.42$8.12+9.43%$8.25$7.351.20 million shs$558.75 million06/02/2025$7.21$7.42+2.91%$7.63$7.111.18 million shs$510.58 million05/30/2025$7.21$7.21$7.58$6.862.15 million shs$496.13 million05/29/2025$7.04$7.21+2.41%$7.42$6.85757,824 shs$496.13 million05/28/2025$5.96$7.04+18.12%$7.44$5.882.53 million shs$484.43 million05/27/2025$5.68$5.96+4.93%$6.14$5.571.45 million shs$410.11 million05/26/2025$5.68$5.68$5.70$5.46368,862 shs$390.85 million05/23/2025$5.60$5.68+1.43%$5.70$5.46368,862 shs$390.85 million05/22/2025$5.87$5.60-4.60%$5.90$5.59552,181 shs$385.34 million05/21/2025$6.21$5.87-5.48%$6.19$5.59690,328 shs$403.92 million Related Companies TXG Stock Price Chart TRNS Stock Price Chart ALNT Stock Price Chart CTKB Stock Price Chart LAB Stock Price Chart AEHR Stock Price Chart SENS Stock Price Chart QSI Stock Price Chart MASS Stock Price Chart QTRX Stock Price Chart Receive EYPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eyepoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EYPT) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eyepoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eyepoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
